Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
Status:
Completed
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the within-woman effect of oral micronized progesterone
(Progesterone 300 mg at bedtime) on semi-quantitative menstrual flow measured by the DivaCup®
(menstrual cup with volume indicators at 7.5, 15 and 30 ml) or by counting the number of
soaked normal-sized sanitary products such as normal-sized tampons or pads as well as length
of flow and frequency and severity of menstrual cramps (on a 0-4 scale) in women with hot
flushes and night sweats who are qualified to enroll in the primary perimenopausal hot flush
trial stratified by whether they are in Early or Late Perimenopause.